Cargando…
Radiation dose and survival of patients with stage IV non-small cell lung cancer undergoing concurrent chemotherapy and thoracic three-dimensional radiotherapy: reanalysis of the findings of a single-center prospective study
BACKGROUND: The objective of this study was to evaluate the radiation dose and response in terms of local-regional progression-free survival (LRPFS) and overall survival (OS) of patients with stage IV non-small cell lung cancer (NSCLC) undergoing concurrent chemotherapy and thoracic three-dimensiona...
Autores principales: | Ouyang, Wei-Wei, Su, Sheng-Fa, Hu, Yin-Xiang, Lu, Bing, Ma, Zhu, Li, Qing-Song, Li, Hui-Qin, Geng, Yi-Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4227092/ https://www.ncbi.nlm.nih.gov/pubmed/25001175 http://dx.doi.org/10.1186/1471-2407-14-491 |
Ejemplares similares
-
Overall survival and toxicities regarding thoracic three-dimensional radiotherapy with concurrent chemotherapy for stage IV non-small cell lung cancer: results of a prospective single-center study
por: Su, Sheng-Fa, et al.
Publicado: (2013) -
Prognosis of non-small cell lung cancer patients with bone oligometastases treated concurrently with thoracic three-dimensional radiotherapy and chemotherapy
por: Ouyang, Wei-Wei, et al.
Publicado: (2014) -
The survival outcomes and prognosis of stage IV non-small-cell lung cancer treated with thoracic three-dimensional radiotherapy combined with chemotherapy
por: Su, ShengFa, et al.
Publicado: (2014) -
Radiation recall pneumonitis induced by chemotherapy after thoracic radiotherapy for lung cancer
por: Ding, Xiao, et al.
Publicado: (2011) -
Three-Dimensional Conformal Radiotherapy-Based or Intensity-Modulated Radiotherapy-Based Concurrent Chemoradiotherapy in Patients with Thoracic Esophageal Squamous Cell Carcinoma
por: Lin, Wei-Cheng, et al.
Publicado: (2019)